Chairman Of Indian Pharmacopoeia Commission [2021]

Chaired by the Union Health Secretary (Chairman of IPC), this body oversees the commission’s overall policies and financial allocations.

The Indian pharmaceutical industry is the "pharmacy of the world," supplying over 60% of global vaccines and 20% of generic medicines. The IPC, established in 1956 (and reconstituted under the Ministry of Health & Family Welfare), publishes the Indian Pharmacopoeia (IP). However, the office of its —typically a senior scientist or bureaucrat—carries unique weight. Unlike Western counterparts (e.g., the US Pharmacopoeia CEO), the IPC Chairman operates within a developing nation's complex matrix of affordability, patent law, and public health emergencies. chairman of indian pharmacopoeia commission

The is an ex-officio position held by the Secretary of the Ministry of Health and Family Welfare (MoHFW) , Government of India . As of late 2024, Ms. Punya Salila Srivastava serves in this capacity. Chaired by the Union Health Secretary (Chairman of

[Your Name/Affiliation] Date: [Current Date] However, the office of its —typically a senior

Promoting the recognition of IP standards globally and harmonizing them with other major pharmacopoeias like the USP, BP, and EP.

The Chairman of the Indian Pharmacopoeia Commission is not merely a titular head but the gatekeeper of a trillion-rupee pharmaceutical ecosystem. To maintain India’s reputation as a reliable drug supplier, the government should: